Michael Press, M.D., Ph.D.

University of Southern California
email: villalob@usc.edu

Grants

HER2 Co-Amplified Genes and Treatment Response 2010 (Cycle 16)
IDEA (Innovative, Developmental, and Exploratory Awards) 16IB-0098 $241,988
Topoisomerase-IIa as a Predictor of Anthracycline Response 2008 (Cycle 14)
IDEA-competitive renewal 14NB-0179 $405,393
Topoisomerase-IIa as a Predictor of Anthracycline Response 2006 (Cycle 12)
IDEA (Innovative, Developmental, and Exploratory Awards) 12IB-0155 $244,499
USC/NCCC Breast Cancer Research Training Program 2002 (Cycle VIII)
Training Program 8TB-0097 $266,759
HER-2/neu Gene Variations and Breast Cancer Risk 2001 (Cycle VII)
RFA (Request for Applications) 7PB-0051S $1,182,463
Can Molecular Markers Predict Response to Adjuvant Therapy? 1999 (Cycle V)
TRC (Translational Research Collaboration) Full Research Awards 5EB-3101 $508,813
Breast Cancer Markers and Response to Adjuvant Therapy 1998 (Cycle IV)
TRC (Translational Research Collaboration) Pilot Awards 4DB-5201 $0
Genes Which Cause Increased Cellular DNA in Breast Cancer 1995 (Cycle I)
Research Project Awards 1RB-0203 $493,585


HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
  Periodical: Journal of Clinical Oncology
  Author(s): Press, MF, Sauter, G, Buyse M, Fourmanoir, Helene, Quinaux, E, Tsao-Wei D, et al.
  Yr: 2016 Vol: Nbr: Pgs:
  Associated Grant: HER2 Co-Amplified Genes and Treatment Response
 
HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics.
  Periodical: Breast Cancer Research and Treatment
  Author(s): Fasching PA, Weihbrecht, S, Gasparyan A, et al.
  Yr: 2014 Vol: 145 Nbr: 1 Pgs: 193-203
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Adjuvant Trastuzumab in HER2-Positive Breast Cancer: Authors' Reply.
  Periodical: New England Journal of Medicine
  Author(s): Slamon DJ, Buyse M. Press MF
  Yr: 2012 Vol: 366 Nbr: Pgs: 663-666
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Potential utility of an expression array signature for predicting anthracycline responsiveness or resistance.
  Periodical: Journal of Clinical Oncology
  Author(s): Press MF, Gordon MA, Slamon DJ
  Yr: 2012 Vol: 30 Nbr: 4 Pgs: 357-61
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.
  Periodical: Journal of Clinical Oncology
  Author(s): Press MF, Sauter G, Buyse M, Bernstein L, et al, and Slamon D
  Yr: 2011 Vol: 29 Nbr: 7 Pgs: 859-67
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Adjuvant Trastuzumab in HER2-Positive Breast Cancer.
  Periodical: New England Journal of Medicine
  Author(s): Slamon, Eiermann, Nicholas Robert, Pienko, Press, et al.
  Yr: 2011 Vol: 365 Nbr: Pgs: 1273-83
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Does topoisomerase II-alpha gene amplification provide useful information for treatment selection in patients with breast carcinoma? In reply to R. Simon.
  Periodical: Journal of Clinical Oncology
  Author(s): Press MF, Bernstein L, Sullivan-Halley J, Buyse M, Sauter G, Slamon DJ
  Yr: 2011 Vol: 29 Nbr: Pgs: 2941-2944
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Association with anthracycline sensitivity in human breast cancers.
  Periodical: Journal National Cancer Institute
  Author(s): Slamon DJ and Press MF
  Yr: 2009 Vol: 101 Nbr: Pgs: 615-618
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Alteration of Topoisomerase II-alpha Gene in Human Breast Cancer: Association with Responsiveness to Anthracycline-Based Chemotherapy.
  Periodical: New England Journal of Medicine
  Author(s): Press MF, Sauter G, Buyse M, Bernstein L, et al, and Slamon DJ
  Yr: 2009 Vol: Nbr: Pgs:
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
Use of Trastuzumab in the Adjuvant Treatment of HER2-Positive Breast Cancer: Efficacy and Safety Results from the BCIRG-006 Study
  Periodical: New England Journal of Medicine
  Author(s): Slamon DJ, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al.
  Yr: 2009 Vol: Nbr: Pgs:
  Associated Grant: Topoisomerase-IIa as a Predictor of Anthracycline Response
 
GAC63, a GRIP1-dependent nuclear receptor coactivator.
  Periodical: Molecular and Cellular Biology
  Author(s): Chen YH, Kim JH, Stallcup MR.
  Yr: 2005 Vol: 25 Nbr: 14 Pgs: 5965-72
  Associated Grant: USC/NCCC Breast Cancer Research Training Program
 
Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: what is in common?
  Periodical: Differentiation
  Author(s): Mayer JA, Chuong CM, Widelitz R.
  Yr: 2004 Vol: 27 Nbr: 9-10 Pgs: 474-488
  Associated Grant: USC/NCCC Breast Cancer Research Training Program
 
The biology of feather follicles.
  Periodical: International Journal of Developmental Biology
  Author(s): Yu M, Yue Z, Wu P, Wu DY, Mayer JA, Medina M, Widelitz RB, Jiang TX, Chuong CM.
  Yr: 2004 Vol: 48 Nbr: 2-3 Pgs: 181-191
  Associated Grant: USC/NCCC Breast Cancer Research Training Program
 
Body weight correlates with mortality in early-stage breast cancer.
  Periodical: Archives of Surgery
  Author(s): Enger SM, Greif JM, Polikoff J, Press M.
  Yr: 2004 Vol: 139 Nbr: 9 Pgs: 954-958
  Associated Grant: Can Molecular Markers Predict Response to Adjuvant Therapy?
 
WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium
  Periodical: American Journal of Pathology
  Author(s): Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen W, Felix J, Jones L, Hall F, Press M
  Yr: 1997 Vol: 150 Nbr: 1 Pgs: 167-175
  Associated Grant: Genes Which Cause Increased Cellular DNA in Breast Cancer